Correspondence: First Peanut ( Arachis hypogaea ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
Year: 2026
Type: letter
Source: Allergy
DOI: 10.1111/all.70261
Institutions: Bambino Gesù Children's Hospital, Zentrum für Rhinologie und Allergologie, Hospital Sant Joan de Déu Barcelona, Institut de Recerca Sant Joan de Déu, Universitat de Barcelona, Baylor College of Medicine, Texas Children's Hospital, Université de Montréal, Charité - Universitätsmedizin Berlin, Goethe University Frankfurt, Stanford University, National Sagamihara Hospital, University of Toronto, Universitätsklinikum St. Pölten, Karl Landsteiner University of Health Sciences, Azienda Ospedale - Università Padova, NIHR Imperial Biomedical Research Centre, Imperial College London, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Hospital for Sick Children, Sickkids Research Institute
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Danone, Regeneron Pharmaceuticals, Nestlé Health Science, Innovationsfonden, Immune Tolerance Network, Aimmune Therapeutics, Mylan, Allergy Therapeutics, Celltrion, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Bundesministerium für Ernährung und Landwirtschaft, Hospital for Sick Children, European Academy of Allergy and Clinical Immunology, Bausch Health, Food Allergy Canada, Genentech, Novartis Pharma, Allergopharma, Canadian Institutes of Health Research, Medical Research Council, Instituto de Salud Carlos III, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W7128712362